Sunday, August 24, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Projections for International Money Express in 2024

Elaine Mendonca by Elaine Mendonca
February 27, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

International Money Express (IntL Money Express) has outlined its financial projections for the first quarter and full year of 2024. The company anticipates the following figures:

Full-year 2024:
– Revenue is estimated to be between $681.0 million and $701.8 million.
– Diluted EPS is forecasted to range from $1.81 to $1.96.
– Adjusted EBITDA is expected to be in the range of $124.0 million to $127.7 million.
– Adjusted Diluted EPS is projected to be between $2.13 and $2.31.

First quarter 2024:
– Revenue is projected to be in the range of $150.4 million to $155.0 million.
– Diluted EPS is expected to be between $0.32 and $0.35.
– Adjusted EBITDA is forecasted to range from $24.4 million to $25.1 million.
– Adjusted Diluted EPS is estimated to be between $0.39 and $0.42.

Overall, International Money Express is optimistic about its financial performance for the year ahead.

IMXI Stock Plummets 9.86% in One Day: Can It Recover?

IMXI stock had a rough day on February 27, 2024, as it experienced a significant drop in price. The stock opened at $19.90, which was $1.60 lower than its previous close. Throughout the day, the price of IMXI shares continued to decrease, ending the day at $17.78. This marked a $2.12 drop from the previous close, representing a 9.86% decrease in value.

Investors and analysts may be watching closely to see if IMXI can reverse this downward trend and start to show some positive momentum. It will be important to monitor the stock’s performance in the coming days and weeks to see if it can recover from this significant drop in price.

IMXI Stock Reports Positive Financial Results for Past Year and Q3 2024

IMXI stock had a mixed performance on February 27, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, IMXI’s total revenue for the past year was $473.88 million, which represented a 19.56% increase compared to the previous year. Net income for the past year was $57.33 million, showing a 22.39% increase compared to the previous year. Earnings per share (EPS) for the past year were $1.48, showing a 23.91% increase compared to the previous year. Overall, IMXI’s financial performance showed positive growth in terms of total revenue, net income, and EPS compared to the previous year. Investors may want to closely monitor IMXI’s performance in the coming quarters to assess its future growth potential.

Tags: IMXI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Trading online

Portillos Projects Significant Growth in Restaurant Units and Revenue

Data-security

Expansion of SOBR Safe Inc in Canada through Strategic Partnership with TrTek Monitoring Services

Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

Recommended

Biotechnology Stock Exchange

Perions Groundbreaking Partnership with Wayio Expanding into Chinas Booming Digital Market

1 year ago
Mining technology

Webull Corporation to Go Public through SPAC Merger A GameChanging Move in Digital Investing

1 year ago

MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder

1 year ago

Supernus Pharmaceuticals Wins Patent Infringement Case Secures Exclusivity for Trokendi XR

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN Apple AVGO BA C CELH COIN Coinbase COST CRWD DELL DIS DWAC Eli Lilly EQT GM GRFS IBM INTC JPM LLY META Micron MSFT NFLX NIO NVDA NVO PARA PLTR PLUG Robinhood SMCI Strategy TGT TSLA UNH VZ
No Result
View All Result

Highlights

Can Nike’s Jordan Brand Reclaim Its Air?

Rafael Holdings Shares Stage a Tentative Rebound After Steep Declines

B&G Foods Stock: Can Strategic Shifts Offset Persistent Headwinds?

Gilead Sciences: Navigating Setbacks and Strategic Investments

Fiserv Faces Class Action Lawsuit Over Business Practices

Oxford Lane Capital Shares Tumble on Unexpected Earnings Shortfall

Trending

Procter & Gamble Stock
Stocks

Insider Selling Spree Raises Questions at Procter & Gamble

by Dieter Jaworski
August 24, 2025
0

A significant wave of insider selling activity at Procter & Gamble is drawing investor scrutiny. Corporate leaders...

Oracle Stock

Oracle’s AI Ambition: Market Optimism Meets Investor Skepticism

August 24, 2025
Salesforce Stock

Activist Investor Targets Salesforce Amid Market Challenges

August 24, 2025
Nike Stock

Can Nike’s Jordan Brand Reclaim Its Air?

August 24, 2025
Rafael Stock

Rafael Holdings Shares Stage a Tentative Rebound After Steep Declines

August 24, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Insider Selling Spree Raises Questions at Procter & Gamble August 24, 2025
  • Oracle’s AI Ambition: Market Optimism Meets Investor Skepticism August 24, 2025
  • Activist Investor Targets Salesforce Amid Market Challenges August 24, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Cryptocurrency
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com